Stents for Prostatic Diseases: Any Progress after 25 Years?
Wednesday, 01 February 2006
Stephan Madersbacher, Department of Urology and Andrology, Donauspital, Vienna, AustriaThe use of an endoprosthesis to maintain luminal patency is a well-established concept in a variety of surgical settings, including cardiovascular and gastrointestinal pathologies. First reports on the use of prostatic stents were published in the 1980s for benign prostatic obstruction (BPO).
read more
|
Varicocelectomy, Evidence-Based Medicine and Fallibility
Wednesday, 01 February 2006
Jeremy P.W. Heaton Queen's University, Kingston, Canada In this issue of European Urology Ficarra and colleagues present a view of the management of varicoceles in subfertile men [1]. It is clear from their report that there is only a small amount of high quality data available regarding the subject so definitive conclusions will be difficult to reach.
read more
|
Substaging Pathologically Organ Confined (pT2) Prostate Cancer: An Exercise in Futility?
Wednesday, 01 February 2006
Th. H. van der Kwast, Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada The anatomical extent of a malignant tumour at the different stages of its development is represented by the staging system. The most common objective of staging is to group malignancies with a similar prognosis and therapeutical approach.
read more
|
Watchful Waiting Policy in Recurrent Ta G1 Bladder Tumors
Wednesday, 01 February 2006
Objective: To determine the outcome of a watchful waiting policy in patients suffering from small, recurrent, papillary bladder tumors.
read more
|
